홈 › 크론병 › 뉴욕

뉴욕의 크론병 임상 시험

크론병 관련 연구 35개가 뉴욕 내 여러 지역에서 참여자를 모집하고 있습니다.

뉴욕의 도시

공식 연구 텍스트(영어)

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

NYU Langone Hospital - Long Island, Mineola
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
외 1개

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT03816345

A Study of SL-325 in Crohn's Disease Patients

Clinical Trial Site, Maspeth

피험자 모집 중2상

18세 ~ 80세 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07753850

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

New York Gastroenterology Associates ( Site 0253), New York

피험자 모집 중3상

전 연령 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06651281

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Northwell Health Physician Partners Center for Advanced IBD Care ( Site 5017), Great Neck
NYU Langone Health - Inflammatory Bowel Disease Center (IBD) ( Site 5078), New York
Weill Cornell Medical College, New-York Presbyterian Hospital ( Site 5079), New York
외 2개

피험자 모집 중3상

16세 ~ 80세 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06430801

Iron Treatment for Iron Deficiency Anemia in Children and Young Adults With Crohn's Disease

Weill Cornell Medicine, New York

피험자 모집 중4상

3세 ~ 21세 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT07925450

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

New York Gastroenterology Associates, New York
Care Access - Yonkers, Yonkers

피험자 모집 중3상

18세 ~ 70세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06937099

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Westchester Putnam Gastroenterology, Carmel
Inflammatory Bowel Disease Center at NYU Langone, New York
Weill Cornell Medical College, New York
외 2개

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07196722

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

New York Gastroenterology Associates, New York
GIA Rochester, Rochester

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07577843

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Weill Cornell Medical College - Judith Jaffe Multiple Sclerosis Center, New York
Icahn School of Medicine at Mount Sinai, New York
Columbia University Medical Center, New York

피험자 모집 중3상

2세 ~ 17세 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT05923073

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Westchester Putnam Gastroenterology, Carmel
New York Gastroenterology Associates, New York

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07499232

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH), New York
Rochester Clinical Research, Inc, Rochester

피험자 모집 중2상

18세 ~ 75세 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT06233461

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Westchester Putnam Gastroenterology PC, Carmel
Five Towns Gastroenterology, Cedarhurst
IMIDeology, Elmhurst
외 5개

피험자 모집 중4상

18세 ~ 80세 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06581328

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

New York Gastroenterology Associates - Upper East Side /ID# 281767, New York

피험자 모집 중2상

18세 ~ 75세 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT07697456

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

MedTraits NY-Site Number: 8400045, Maspeth
NYU Langone Health-Site Number: 8400091, New York
Weill Cornell Medicine - NewYork-Presbyterian Hospital-Site Number: 8400040, New York
외 1개

피험자 모집 중3상

16세 ~ 80세 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT07184944

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

MedTraits NY-Site Number: 8400045, Maspeth
Manhattan Clinical Research, LLC-Site Number: 8400069, New York
NYU Langone Health-Site Number: 8400091, New York
외 4개

피험자 모집 중3상

16세 ~ 80세 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT07184931

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

Icahn School of Medicine at Mount Sinai /ID# 254880, New York

피험자 모집 중3상

2세 ~ 17세 · 모든 성별 · 2026. 10. 20. 업데이트됨 · NCT05995353

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

New York Presbyterian Hospital, New York

피험자 모집 중3상

2세 ~ 17세 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06405087

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Icahn School of Medicine at Mount Sinai, New York

피험자 모집 중3상

2세 ~ 19세 · 모든 성별 · 2026. 10. 7. 업데이트됨 · NCT04844606

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

Weill Cornell Medical College (WCMC) - Judith Jaffe Multiple Sclerosis Center (JJMSC), New York
Icahn School of Medicine at Mount Sinai, New York
Columbia University Medical Center/New York Presbyterian, New York

피험자 모집 중3상

2세 ~ 17세 · 모든 성별 · 2026. 10. 7. 업데이트됨 · NCT05509777

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Nyu Langone Long Island Clinical Research Associates - Lake Success /ID# 265566, Lake Success
Northwell Health-Lenox Hill Hospital /ID# 265527, New York
Care Access - Yonkers /ID# 266781, Yonkers

피험자 모집 중2상

18세 ~ 75세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06548542